This article is 3 years old
Trial vaccine mix-and-match, delayed 2nd dose instead of Ivermectin, MOH told
DAP politician and general practitioner Dr Boo Cheng Hau has questioned the Health Ministry’s decision to trial Ivermectin on high-risk Covid-19 patients.
This comes after India dropped the drug from its Covid-19 treatment guideline.
Ivermectin is an anti-parasitic drug mostly used in veterinary medicine to treat worm infestations...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable